Literature DB >> 3152995

Long term follow-up of bone mineral status in children with renal disease.

R W Chesney1, P Rose, R B Mazess, H F DeLuca.   

Abstract

Bone mineral content (BMC) was measured by photon absorptiometry in the non-dominant forearm of children with chronic renal failure followed for a total of 2472 months. From 48 children, 302 measurements were made, and changes which occurred in BMC over time were correlated with several factors. Patients were divided into those who had received glucocorticoids (group 1) and those who had not (group 2). Group 1 patients had a lower mean serum creatinine (Cr) (p less than 0.05), a lower growth velocity (p greater than 0.02) and were more demineralized than group 2 patients. There was no correlation between BMC and height velocity or estimated creatinine clearance. BMC and height Z-score (SDS) were highly correlated. Over the period of study, group 1 patients remained shorter, had a lower height velocity, a lower BMC Z-score and a lower BMC for each serum creatinine level. Long-term therapeutic intervention with oral 1,25(OH)2D improved bone mineral status in three children in the nonsteroid group, but none of those in the steroid group. This study demonstrates that steroid administration is probably the most important factor causing bone demineralization, possibly even more important than renal failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3152995     DOI: 10.1007/bf00870374

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  Diminution of bone mass in childhood diabetes.

Authors:  A L Rosenbloom; D C Lezotte; F T Weber; J Gudat; D R Heller; M L Weber; S Klein; B B Kennedy
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

2.  Skeletal demineralization in Turner's syndrome.

Authors:  R M Shore; R W Chesney; R B Mazess; P G Rose; G J Bargman
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

3.  The noninvasive determination of bone mineral content by photon absorptiometry.

Authors:  R W Chesney; R M Shore
Journal:  Am J Dis Child       Date:  1982-07

Review 4.  Aluminum.

Authors:  A C Alfrey
Journal:  Adv Clin Chem       Date:  1983       Impact factor: 5.394

5.  Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis.

Authors:  J G Hanly; M J McKenna; C Quigley; R Freaney; F P Muldowney; M X FitzGerald
Journal:  Q J Med       Date:  1985-07

6.  Forearm bone mineral content in children. Normative data.

Authors:  L Landin; B E Nilsson
Journal:  Acta Paediatr Scand       Date:  1981-11

7.  Persistence of diminished bone mineral content following renal transplantation in childhood.

Authors:  R W Chesney; P G Rose; R B Mazess
Journal:  Pediatrics       Date:  1984-04       Impact factor: 7.124

8.  Aluminum loading in children with chronic renal failure.

Authors:  A B Sedman; N L Miller; B A Warady; G M Lum; A C Alfrey
Journal:  Kidney Int       Date:  1984-08       Impact factor: 10.612

9.  Bone mineral status measured by direct photon absorptiometry in childhood renal disease.

Authors:  R W Chesney; R B Mazess; P G Rose; D K Jax
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

10.  Effect of prednisone on growth and bone mineral content in childhood glomerular disease.

Authors:  R W Chesney; R B Mazess; P Rose; D K Jax
Journal:  Am J Dis Child       Date:  1978-08
View more
  3 in total

1.  The impact of corticosteroids on growth and bone health.

Authors:  T Mushtaq; S F Ahmed
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

2.  Bone mineral density and bone metabolism in Duchenne muscular dystrophy.

Authors:  M L Bianchi; A Mazzanti; E Galbiati; S Saraifoger; A Dubini; F Cornelio; L Morandi
Journal:  Osteoporos Int       Date:  2003-07-29       Impact factor: 4.507

3.  Computed tomographic assessment of vertebral bone mineral in childhood.

Authors:  B J Fredericks; J F de Campo; R Sephton; D A McCredie
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.